Prosecution Insights
Prosecution Insights
9 pending office actions • 8 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (11%) |
| §103 only | 1 (11%) |
| §112 only | 2 (22%) |
| Double-patenting only | 1 (11%) |
| Multi-statute (no §101) | 4 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRANKLIN, JODI COHEN | 1 | 61.2% | +25.0% |
| ANTISKAY, BRIAN MICHAEL | 1 | 67.0% | +39.6% |
| BERRY, LAYLA D | 1 | 65.9% | +8.9% |
| ZAHORIK, AMANDA MARY | 1 | 57.5% | +48.2% |
| GEORGE, DENNIS CHERIAN | 1 | 38.5% | +72.7% |
| DENT, ALANA HARRIS | 1 | 44.3% | +32.1% |
| DICKINSON, PAUL W | 1 | 62.8% | +9.9% |
| EVANGELISTA, THEODORE JUSTINE | 1 | 65.6% | +17.2% |
| SHUPE, ELIZABETH A | 1 | 65.7% | +46.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17440067 | PEPTIDE-INDUCED NK CELL ACTIVATION | DICKINSON, PAUL W | 27d |
| 18776905 | METHOD FOR PROCESSING HOLLOW CORE OPTICAL FIBRES | FRANKLIN, JODI COHEN | — |
| 17627385 | ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC PATIENTS | GEORGE, DENNIS CHERIAN | — |
| 17297102 | METHOD FOR FABRICATING NANOSTRUCTURED OPTICAL ELEMENTS USING POLARISED LIGHT | EVANGELISTA, THEODORE JUSTINE | — |
| 17270403 | METHODS AND COMPOSITONS FOR MODULATIONS OF IMMUNE RESPONSE | SHUPE, ELIZABETH A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17625226 | Intratumoral TFR Cells Curtail Anti-PD-1 Treatment Efficacy | DENT, ALANA HARRIS | 84d |
| 18776905 | METHOD FOR PROCESSING HOLLOW CORE OPTICAL FIBRES | FRANKLIN, JODI COHEN | — |
| 18265580 | REFERENCE ELECTRODE & ION SELECTIVE MEMBRANE | ANTISKAY, BRIAN MICHAEL | — |
| 17787061 | PEPTIDE | ZAHORIK, AMANDA MARY | — |
| 17627385 | ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC PATIENTS | GEORGE, DENNIS CHERIAN | — |
| 17297102 | METHOD FOR FABRICATING NANOSTRUCTURED OPTICAL ELEMENTS USING POLARISED LIGHT | EVANGELISTA, THEODORE JUSTINE | — |
| 17270403 | METHODS AND COMPOSITONS FOR MODULATIONS OF IMMUNE RESPONSE | SHUPE, ELIZABETH A | — |
| Art Unit | Apps |
|---|---|
| 1643 | 2 |
| 1741 | 1 |
| 3794 | 1 |
| 1693 | 1 |
| 1636 | 1 |
| 1644 | 1 |
| 1618 | 1 |
| 3700 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18776905 | METHOD FOR PROCESSING HOLLOW CORE OPTICAL FIBRES | FRANKLIN, JODI COHEN | 1741 | §102§103 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18265580 | REFERENCE ELECTRODE & ION SELECTIVE MEMBRANE | ANTISKAY, BRIAN MICHAEL | 3794 | §103 | Final Rejection | — | Pending | Jun 06, 2023 |
| 18247049 | DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME | BERRY, LAYLA D | 1693 | §112 | Non-Final OA | — | Pending | Mar 28, 2023 |
| 17787061 | PEPTIDE | ZAHORIK, AMANDA MARY | 1636 | §112 | Non-Final OA | — | Pending | Jun 17, 2022 |
| 17627385 | ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC PATIENTS | GEORGE, DENNIS CHERIAN | 1644 | §101§103§112Other | Final Rejection | — | Pending | Jan 14, 2022 |
| 17625226 | Intratumoral TFR Cells Curtail Anti-PD-1 Treatment Efficacy | DENT, ALANA HARRIS | 1643 | DP | Non-Final OA | 84d | Pending | Jan 06, 2022 |
| 17440067 | PEPTIDE-INDUCED NK CELL ACTIVATION | DICKINSON, PAUL W | 1618 | §103§112 | Non-Final OA | 27d | Pending | Sep 16, 2021 |
| 17297102 | METHOD FOR FABRICATING NANOSTRUCTURED OPTICAL ELEMENTS USING POLARISED LIGHT | EVANGELISTA, THEODORE JUSTINE | 3700 | §103§112 | Final Rejection | — | Pending | May 26, 2021 |
| 17270403 | METHODS AND COMPOSITONS FOR MODULATIONS OF IMMUNE RESPONSE | SHUPE, ELIZABETH A | 1643 | §103§112 | Final Rejection | — | Pending | Feb 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial